WESTON, Fla., Oct. 28, 2004 (PRIMEZONE) -- TheSUBWAY.com names the following stocks to its Stock Alerts List: Diametrics Medical Inc. (OTCBB:DMED), Novellus Systems Inc. (Nasdaq:NVLS), Juniper Networks Inc. (Nasdaq:JNPR), Brodcade Communications Systems (Nasdaq:BRCD).
Diametrics Medical, Inc. (OTCBB:DMED) just announced that it has signed a non-binding investment term sheet with funds managed by Redwood Grove Capital Management, LLC. The investors propose to invest up to $3,000,000 in two tranches, subject to successful completion of due diligence and negotiation of a definitive agreement. The investment would be used primarily for new product development.
Other stocks highlighted include Novellus Systems Inc. (Nasdaq:NVLS): Stock Standouts List, Juniper Networks Inc. (Nasdaq:JNPR): Stock Standouts List, Brodcade Communications Systems (Nasdaq:BRCD) Stock Standouts List.
TheSUBWAY.com's Daily Stock Updates:
TheSUBWAY.com highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed.
ABOUT TheSUBWAY.com:
TheSUBWAY.com, a leader in corporate communications and finance, provides all investors with a wide-ranging set of financial tools, including original stock market commentary, stock quotes, interactive charts, portfolio watch, live chat and message boards, etc., plus the latest news, press releases, investment opinions, and research reports for all companies highlighted on the site. For more daily commentary, go to http://www.thesubway.com/sub_comm.asp.
All material herein was prepared by Capital Research Group, Inc. (CRG) based upon information believed to be reliable. The information contained herein is not guaranteed by CRG to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com or mentioned herein. CRG has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. (CRG has not been compensated but may purchase up to seventy five thousand dollars worth of dmed stock. If this occurs, CRG will disclose its position fully with each transaction. In addition, CRG could also receive up to two hundred fifty thousand dollars for dmed) CRG intends to sell its shares. CRG has sold approximately zero shares to date. CRG may sell its shares for less than the target price given in this opinion. CRG's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. CRG will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.